The Basics

What is St. John’s Wort / Hypericum perforatum?

Naturally found in the yellow flower of Hypericum perforatum with antidepressant, potential antiviral, antineoplastic and immunostimulating activities.

Brand names for St. John’s Wort / Hypericum perforatum

N/A

How St. John’s Wort / Hypericum perforatum is classified

Anti-Anxiety Agents, Antidepressive Agents, Complementary Therapies, Phytotherapy, Plants, Medicinal


St. John’s Wort / Hypericum perforatum During Pregnancy

St. John’s Wort / Hypericum perforatum pregnancy category

Category N/A
Note that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.

What we know about taking St. John’s Wort / Hypericum perforatum while pregnant

Is it safe to take St. John’s Wort while pregnant? Relevant published information pertaining to St. John’s Wort and pregnancy was not found as of the revision date.


Taking St. John’s Wort / Hypericum perforatum While Breastfeeding

What are recommendations for lactation if you're taking St. John’s Wort / Hypericum perforatum?

St. John’s wort (Hypericum perforatum) contains hypericin and hyperforin as well as flavonoids such as quercetin. It is often recommended by midwives for postpartum depression.[1][2] Both hypericin and hyperforin are poorly excreted into breastmilk; no other components have been measured in milk. One study found a slightly increased frequency of colic, drowsiness and lethargy among breastfed infants whose mothers were taking St. John’s wort, but none of the effects were severe or required treatment. Most reports have related to breastfeeding older infants, rather than during the first 2 months postpartum when infants are more susceptible to adverse reactions. Conflicting information exists on whether St. John’s wort can reduce serum prolactin levels or the maternal milk supply. St. John’s wort adversely interacts with many drugs by increasing their metabolism, and it can occasionally cause phototoxicity. Labeling of commercially available products in the United States is often deficient with respect to these known safety issues.[3] Because there is little published experience with St. John’s wort during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[3] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to prove the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does not certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products.

Maternal / infant drug levels

St. John’s wort (Hypericum perforatum) contains hypericin and hyperforin as well as flavonoids such as quercetin. It is often recommended by midwives for postpartum depression.[1][2] Both hypericin and hyperforin are poorly excreted into breastmilk; no other components have been measured in milk. One study found a slightly increased frequency of colic, drowsiness and lethargy among breastfed infants whose mothers were taking St. John’s wort, but none of the effects were severe or required treatment. Most reports have related to breastfeeding older infants, rather than during the first 2 months postpartum when infants are more susceptible to adverse reactions. Conflicting information exists on whether St. John’s wort can reduce serum prolactin levels or the maternal milk supply. St. John’s wort adversely interacts with many drugs by increasing their metabolism, and it can occasionally cause phototoxicity. Labeling of commercially available products in the United States is often deficient with respect to these known safety issues.[3] Because there is little published experience with St. John’s wort during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.[3] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to prove the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does not certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products.

Possible effects of St. John’s Wort / Hypericum perforatum on milk supply

In a matched cohort study of 33 women who reported that they had taken St. John’s wort during breastfeeding (described in more detail above in Reported Side Effects In Breastfed Infants ), no evidence was found of lower milk production among mothers taking St. John’s wort during breastfeeding.[10]
Thirty-six women with mild premenstrual syndrome received St. John’s wort 450 mg twice daily as coated tablets (Jarsin brand) or placebo for two menstrual cycles. Serum prolactin levels of the women randomized to active treatment (n = 19) were not statistically different from those of the women who received placebo (n = 17) in either the follicular or luteal phase of their menstrual cycles.[11]
Studies in healthy volunteer males (n = 12) given single doses of 2700 mg of St. John’s wort (Jarsin brand) had a drop in serum prolactin that was statistically significant between 150 and 210 minutes after administration.[12]
The prolactin level in a mother with established lactation may not affect her ability to breastfeed.

Possible alternatives to St. John’s Wort / Hypericum perforatum

Nortriptyline, Paroxetine, Sertraline.


List of References

Lactation sources: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/

1. Allaire AD, Moos MK, Wells SR. Complementary and alternative medicine in pregnancy: a survey of North Carolina certified nurse-midwives. Obstet Gynecol. 2000;95:19-23. PMID: 10636495
2. Dennehy C, Tsourounis C, Bui L, King TL. The use of herbs by California midwives. J Obstet Gynecol Neonatal Nurs. 2010;39:684-93. PMID: 21044150
3. Clauson KA, Santamarina ML, Rutledge JC. Clinically relevant safety issues associated with St. John’s wort product labels. BMC Complement Altern Med. 2008;8:42. PMID: 18637192
4. Wurglics M, Westerhoff K, Kaunzinger A et al. Comparison of German St. John’s wort products according to hyperforin and total hypericin content. J Am Pharm Assoc (Wash). 2001;41:560-6. PMID: 11486982
5. Klier CM, Schafer MR, Schmid-Siegel B et al. St. John’s wort (Hypericum perforatum) — is it safe during breastfeeding? Pharmacopsychiatry. 2002;35:29-30. PMID: 11819157
6. Klier CM, Schmid-Siegel B, Schafer MR et al. St. John’s wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants. J Clin Psychiatry. 2006;67:305-9. PMID: 16566628
7. Song BJ, Jouni ZE, Ferruzzi MG. Assessment of phytochemical content in human milk during different stages of lactation. Nutrition. 2013;29:195-202. PMID: 23237648
8. Romaszko E, Wiczkowski W, Romaszko J, Honke J, Piskula MK. Exposure of breastfed infants to quercetin after consumption of a single meal rich in quercetin by their mothers. Mol Nutr Food Res. 2014;58:221-8. PMID: 23963751
9. Grush LR, Nierenberg A, Keefe B, Cohen LS. St John’s wort during pregnancy. JAMA. 1998;280:1566. Letter. PMID: 9820253
10. Lee A, Minhas R, Matsuda N et al. The safety of St. John’s wort (Hypericum perforatum) during breastfeeding. J Clin Psychiatry. 2003;64:966-8. PMID: 12927015
11. Canning S, Waterman M, Orsi N et al. The efficacy of Hypericum perforatum (St John’s wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24:207-25. PMID: 20155996
12. Franklin M , Cowen PJ. Researching the antidepressant actions of Hypericum perforatum (St. John’s wort) in animals and man. Pharmacopsychiatry. 2001;34 (Suppl 1):S29-37. PMID: 11518072


Disclaimer: This material is provided for educational purposes only and is not intended for medical advice, diagnosis, or treatment. Consult your healthcare provider with any questions.

Read This Next

Protriptyline

Protriptyline and pregnancy or breastfeeding: Is it safe?

Read More

As seen in

Join our mailing list

Sign up for access to exclusive promotions, latest news and opportunites to test new pre-release products